Skip to main content
. 2020 Oct 18;14:1753466620963016. doi: 10.1177/1753466620963016

Table 1.

Patient characteristics.

Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age, years 60 55 62 89 75
Gender Female Male Female Female Male
Smoking habit No No No No Yes
Comorbidities Hypercholesterolemia Diabetes, previous TIA, infantile meningitis with cognitive developmental delay, hyperthyroidism, chronic gastritis, chronic liver disease. Microcytic anaemia, paroxysmal atrial fibrillation. Arterial hypertension, severe arthrosis. Idiopathic pulmonary fibrosis, Parkinson’s disease, diabetes mellitus, renal failure, atrial fibrillation.
Admission therapy Statin Promazine Clothiapine
Omeprazole
Insulin therapy
Bisoprolol
Pantoprazole
Pantoprazole
Ace-inhibitor
Furosemide
Bisoprolol
Ace-inhibitor
Nintedanib
Insulin therapy
Hospitalisation therapy Hydroxycloroquine Azithromycin
Enoxaparin
Metilprednisolone
Empiric antibiotic therapy
Tocilizumab
Hydroxycloroquine
Azithromycin
Enoxaparin
Metilprednisolone
Empiric antibiotic therapy
Hydroxycloroquine Azithromycin
Enoxaparin
Metilprednisolone
Hydroxycloroquine Azithromycin
Enoxaparin
Metilprednisolone
Enoxaparin
Metilprednisolone
Insulin therapy
Furosemide
Empiric antibiotic therapy

TIA, transient ischaemic attack.